PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 5 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4 | -100.0% | 172,958 | 0.0% | 0.00% | – |
Q3 2022 | $29,000 | -82.3% | 172,958 | -36.6% | 0.00% | -100.0% |
Q2 2022 | $164,000 | -61.7% | 272,770 | -16.1% | 0.00% | -50.0% |
Q1 2022 | $428,000 | -49.5% | 325,260 | -0.0% | 0.00% | -33.3% |
Q4 2021 | $847,000 | +2071.8% | 325,395 | +2492.8% | 0.00% | – |
Q3 2021 | $39,000 | – | 12,550 | +8994.2% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 138 | -99.0% | 0.00% | – |
Q4 2019 | $84,000 | +300.0% | 13,799 | +179.4% | 0.00% | – |
Q3 2019 | $21,000 | – | 4,939 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 1,607,044 | $4,194,000 | 0.48% |
NEA Management Company, LLC | 6,643,704 | $17,340,000 | 0.35% |
Platform Technology Partners | 251,723 | $657,000 | 0.29% |
DAFNA Capital Management LLC | 378,611 | $988,000 | 0.25% |
Avidity Partners Management LP | 4,405,000 | $11,497,000 | 0.24% |
Endurant Capital Management LP | 360,078 | $940,000 | 0.23% |
Rock Springs Capital Management LP | 2,581,299 | $6,737,000 | 0.16% |
RA Capital Management | 2,850,000 | $7,439,000 | 0.13% |
New Legacy Group, LLC | 240,575 | $628,000 | 0.12% |
XTX Topco Ltd | 15,574 | $41,000 | 0.02% |